These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1973915)

  • 1. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
    Lohmann FW
    Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta receptor blockers in dilated cardiomyopathy (clinical aspects)].
    Sigmund M; Reineke T
    Z Kardiol; 1992; 81 Suppl 4():65-70. PubMed ID: 1363261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-adrenergic blocking agents in congestive heart failure.
    Krukemyer JJ
    Clin Pharm; 1990 Nov; 9(11):853-63. PubMed ID: 1980240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adrenergic betablockers and heart failure].
    Lechat P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):611-5. PubMed ID: 7487311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of dilated cardiomyopathy with special reference to the role of beta-blockers.
    Waagstein F
    Herz; 1985 Jun; 10(3):143-8. PubMed ID: 2862098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of dilated cardiomyopathy with digitalis, diuretics and vasodilators].
    Liebau G
    Herz; 1985 Jun; 10(3):138-42. PubMed ID: 2991095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here?
    Anderson JL
    Postgrad Med; 1988 Feb; Spec No():104-12. PubMed ID: 2894653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-adrenergic blockers in congestive heart failure: pro et contra?].
    Trifunović SL; Pavlović K
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():44-50. PubMed ID: 18193810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormality in plasma catecholamines and myocardial adrenoceptors in cardiomyopathic BIO 53.58 Syrian hamsters and improvement by metoprolol treatment.
    Yamada S; Ohkura T; Yamadera T; Ito O; Kimura R; Nozawa Y; Hayashi S; Miyake H
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1389-95. PubMed ID: 9400015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression and beta-blockade in heart failure.
    Lee HR; O'Connell JB; Mason JW
    Cardiol Clin; 1989 Feb; 7(1):171-81. PubMed ID: 2565162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
    Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of third-generation beta-blockers in heart failure.
    Chatterjee K
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S22-7. PubMed ID: 2481786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.